Actual Medicinal Product (AMP) Ezetimibe 10mg tablets (Medreich Plc)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicine. Store in airtight (sealed) MCA. Manufacturer recommends storing in original container.
No stability data in MCAs available. - Provenance
-
This recommendation is based on the products Ezetrol 10mg tablets (Organon Pharma (UK) Limited) and Ezetimibe 10mg tablets (Aurobindo Pharma – Milpharm Ltd).
- Generic
- Ezetimibe
- Formulation
- Ezetimibe 10mg tablets
-
Ezetimibe
-
Ezetimibe 10mg tablets
-
Ezetimibe 10mg tablets (Medreich Plc)
-
-